|
|
Neurovascular Crisis: Caring for the Stroke Patient (eLearning)
This course provides a more advanced review of the ischemic and hemorrhagic stroke patient. It also offers a comprehensive review of anatomy, assessments and diagnostics, providing an in-depth refresher on the pathophysiology and care of the stroke patient. It reviews the various types of strokes and interventions, both pharmacologic and endovascular. The course covers the comorbidities of stroke in present-day patients; it also covers the complications and bed-side treatment modalities, such ... |
|
|
Neurovascular Crisis: Caring for the Stroke Patient (DVD-ROM)
This course provides a more advanced review of the ischemic and hemorrhagic stroke patient. It also offers a comprehensive review of anatomy, assessments and diagnostics, providing an in-depth refresher on the pathophysiology and care of the stroke patient. It reviews the various types of strokes and interventions, both pharmacologic and endovascular. The course covers the comorbidities of stroke in present-day patients; it also covers the complications and bed-side treatment modalities, such ... |
|
|
Geographic Atrophy Secondary to Age-Related Macular Degeneration: Innovative Therapies for Sight Revival
Multimodal imaging is key for the early detection and monitoring of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Optical coherence tomography has recently been recommended by an international consensus to be the primary imaging method for the detection of atrophy in eyes. Once diagnosed, timely therapeutic intervention should be initiated with recently FDA-approved therapies that target components of the complement cascade. When optimally integrated into persona... |
|
|
Improving the Diagnosis and Management of Pulmonary Progressive Fibrosis (PPF): A Focus on Systemic Sclerosis Interstitial Lung Disease (SSc-ILD) and Idiopathic Pulmonary Fibrosis (IPF)
Target Audience
This activity is designed to meet the educational needs of rheumatologists, pulmonologists, and advanced practice providers.
Program Overview
This activity features an interactive case-based format where you can review questions to determine best practices in diagnosing and managing PPF, SSc-ILD, and IPF. This session offers real-life examples to help differentiate diseases within the Pulmonary Progressive Fibrosis (PPF) group, such as Idiopathic Pulmonary Fibrosis (IPF) a... |
|
|
Management of Cancer Pain: Current Guidelines
STATEMENT OF NEED
Patients with cancer often suffer from a range of symptoms that negatively impact their quality of life. Among the most significant of these symptoms is pain, which can be caused by surgery, radiation, chemotherapy, targeted therapy, diagnostic procedures, and/or supportive care measures. Between 20% and 50% of patients with cancer experience pain, including moderate-to-severe pain in approximately 80% of patients with advanced-stage cancer (NCI, 2023). Despite awareness a... |
|
|
Cognitive Impairment Associated With Schizophrenia: Evaluating Emerging Therapies
Target Audience
This educational activity has been designed to meet the needs of psychiatrists, psychiatry mental health therapists (eg, psychologists, social workers, case managers), nurse practitioners, physician assistants, pharmacists, primary care providers, and other clinicians involved in the management of patients with cognitive impairment associated with schizophrenia (CIAS).
Program Overview
CIAS is a core symptom domain of schizophrenia that can impose even greater long-term da... |
|
|
Management of Venous Thromboembolism in Ambulatory Patients With Cancer
STATEMENT OF NEED
Venous thromboembolism (VTE) is a common and potentially deadly complication in patients with cancer. The risk of cancer-related VTE has risen in the past 2 decades, with up to 15% of patients with cancer now experiencing VTE. Oncology nurses are ideally situated to assist in the identification of patients at risk for thrombotic events. This activity will discuss strategies for early identification of patients receiving outpatient (ambulatory) chemotherapy who are at high ... |
|
|
Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape
Target Audience
This educational activity is directed toward hematologists and hematologist-oncologists, as well as pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with beta-thalassemia.
Program Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of β-thalassemia, with a forward-looking perspective on how new and novel agents might imp... |
|